Urispas 200

Urispas 200 Special Precautions

flavoxate

Manufacturer:

Recordati

Distributor:

DCH Auriga
Full Prescribing Info
Special Precautions
The use in children below the age of <12 years is not recommended.
Since the renal clearance of the active metabolite accounts more than 50% of the dose, renal impairment may significantly affect the product kinetics. Caution is therefore required in patients with renal impairment.
As the tablets contain lactose, its use is not recommended in patients with rare hereditary problems of galactose intolerance, the total lactase deficiency or glucose-galactose malabsorption. In the event of drowsiness and blurred vision, the patient should not drive a motor vehicle or operate machinery.
The use in children below the age of <12 years is not recommended.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in